Literature DB >> 33785354

Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca2+ channels as sensors.

Iwona Ruchala1, Umberto M Battisti2, Vy T Nguyen1, Rita Yu-Tzu Chen1, Richard A Glennon2, Jose M Eltit3.   

Abstract

The early characterization of ligands at the dopamine and serotonin transporters, DAT and SERT, respectively, is important for drug discovery, forensic sciences, and drug abuse research. 4-Methyl amphetamine (4-MA) is a good example of an abused drug whose overdose can be fatal. It is a potent substrate at DAT and SERT where its simplest secondary amine (N-methyl 4-MA) retains substrate activity at them. In contrast, N-n-butyl 4-MA is very weak, therefore it was categorized as inactive at these transporters. Here, N-octyl 4-MA and other related compounds were synthesized, and their activities were evaluated at DAT and SERT. To expedite this endeavor, cells expressing DAT or SERT were co-transfected with a voltage-gated Ca2+ channel and, the genetically-encoded Ca2+ sensor, GCaMP6s. Control compounds and the newly synthesized molecules were tested on these cells using an automated multi-well fluorescence plate reader; substrates and inhibitors were identified successfully at DAT and SERT. N-Octyl 4-MA and three bivalent compounds were inhibitors at these transporters. These findings were validated by measuring Ca2+-mobilization using quantitative fluorescence microscopy. The bivalent molecules were the most potent of the series and were further characterized in an uptake-inhibition assay. Compared to cocaine, they showed comparable potency inhibiting uptake at DAT and higher potency at SERT. These observations support a previous hypothesis that amphetamine-related (and, here, N-extended alkyl and) bivalent arylalkylamine molecules are active at monoamine transporters, showing potent activity as reuptake inhibitors, and implicate the involvement of a distant auxiliary binding feature to account for their actions at DAT and SERT.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium imaging; Monoamine transporters; Psychostimulants; Reuptake inhibitors; Voltage-gated calcium channels

Mesh:

Substances:

Year:  2021        PMID: 33785354      PMCID: PMC8148225          DOI: 10.1016/j.taap.2021.115513

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  46 in total

1.  Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.

Authors:  Jacob Andersen; Lucy Kate Ladefoged; Trine N Bjerre Kristensen; Lachlan Munro; Julie Grouleff; Nicolai Stuhr-Hansen; Anders S Kristensen; Birgit Schiøtt; Kristian Strømgaard
Journal:  ACS Chem Neurosci       Date:  2016-08-10       Impact factor: 4.418

2.  Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Authors:  Gregory T Collins; Agnieszka Sulima; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2019-07-26       Impact factor: 4.530

Review 3.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

Review 4.  A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).

Authors:  Alok Sharma; Justin Couture
Journal:  Ann Pharmacother       Date:  2013-11-01       Impact factor: 3.154

Review 5.  Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.

Authors:  N D Volkow; J S Fowler; G J Wang
Journal:  J Psychopharmacol       Date:  1999-12       Impact factor: 4.153

6.  Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.

Authors:  M S Sonders; S J Zhu; N R Zahniser; M P Kavanaugh; S G Amara
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

7.  Amphetamine activates calcium channels through dopamine transporter-mediated depolarization.

Authors:  Krasnodara N Cameron; Ernesto Solis; Iwona Ruchala; Louis J De Felice; Jose M Eltit
Journal:  Cell Calcium       Date:  2015-07-02       Impact factor: 6.817

8.  4-Methyl-amphetamine: a health threat for recreational amphetamine users.

Authors:  P Blanckaert; Jgc van Amsterdam; Tm Brunt; Jdj van den Berg; F Van Durme; K Maudens; Jch van Bussel
Journal:  J Psychopharmacol       Date:  2013-06-19       Impact factor: 4.153

9.  Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.

Authors:  Jonathan A Coleman; Dongxue Yang; Zhiyu Zhao; Po-Chao Wen; Craig Yoshioka; Emad Tajkhorshid; Eric Gouaux
Journal:  Nature       Date:  2019-04-24       Impact factor: 49.962

10.  Ultrasensitive fluorescent proteins for imaging neuronal activity.

Authors:  Tsai-Wen Chen; Trevor J Wardill; Yi Sun; Stefan R Pulver; Sabine L Renninger; Amy Baohan; Eric R Schreiter; Rex A Kerr; Michael B Orger; Vivek Jayaraman; Loren L Looger; Karel Svoboda; Douglas S Kim
Journal:  Nature       Date:  2013-07-18       Impact factor: 49.962

View more
  1 in total

1.  Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.

Authors:  Tyler W E Steele; Zachary Spires; Charles B Jones; Richard A Glennon; Małgorzata Dukat; Jose M Eltit
Journal:  Neuropharmacology       Date:  2021-10-04       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.